BusinessCURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.By Nasdaq OMXMar 21, 2017, 12:31 PM UTC
BusinessApricus Biosciences Announces Sale of Ex-U.S. Vitaros Assets and Rights to Ferring PharmaceuticalsBy Nasdaq OMXMar 8, 2017, 9:01 PM UTC
BusinessEntia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products LineBy Nasdaq OMXFeb 24, 2017, 9:01 PM UTC
BusinessArbutus Is Granted a Pre-trial Injunction Restraining Acuitas From Entering Into Agreements Sublicensing Arbutus LNP TechnologyBy Nasdaq OMXFeb 8, 2017, 11:00 AM UTC
BusinessMetabolon and Dian Enter Into Metabolomics Laboratory Licensing Agreement in ChinaBy Nasdaq OMXFeb 6, 2017, 2:45 PM UTC
BusinessMercury Systems Launches CANGuard to Strengthen Automotive Data SecurityBy Nasdaq OMXJan 30, 2017, 9:19 PM UTC
BusinessApricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in MexicoBy Nasdaq OMXJan 18, 2017, 12:00 PM UTC
BusinessOSE Immunotherapeutics signs a license option agreement with Servier to develop and commercialize the product Effi-7By Nasdaq OMXDec 27, 2016, 11:01 PM UTC
